Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 15, Issue 6

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 15, Issue 6 (2006)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 15, Issue 6 (2006)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Volume 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Article

Apoptosis: the suicide solution in cancer treatment and chemoprevention

Gerasimos P Sykiotis & Athanasios G Papavassiliou

Pages: 575-577

Published online: 30 May 2006

AbstractforApoptosis: the suicide solution in cancer treatment and chemoprevention | Full Text | References | PDF (79.2 KB)

57 Views
7 CrossRef citations
0Altmetric

Review

Article

Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations

George Aperis & Eleftherios Mylonakis

Pages: 579-602

Published online: 30 May 2006

AbstractforNewer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations | Full Text | References | PDF (279.7 KB)

307 Views
69 CrossRef citations
0Altmetric

Article

Development potential of rifalazil and other benzoxazinorifamycins

David M Rothstein, Christo Shalish, Christopher K Murphy, Andrew Sternlicht & Lee Ann Campbell

Pages: 603-623

Published online: 30 May 2006

AbstractforDevelopment potential of rifalazil and other benzoxazinorifamycins | Full Text | References | PDF (295.4 KB)

146 Views
31 CrossRef citations
0Altmetric

Article

Therapeutic potential of angiotensin receptor blockers in hypertension

Bernard MY Cheung

Pages: 625-635

Published online: 30 May 2006

AbstractforTherapeutic potential of angiotensin receptor blockers in hypertension | Full Text | References | PDF (176.9 KB)

170 Views
5 CrossRef citations
0Altmetric

Article

New antiepileptic drugs that are second generation to existing antiepileptic drugs

Meir Bialer

Pages: 637-647

Published online: 30 May 2006

AbstractforNew antiepileptic drugs that are second generation to existing antiepileptic drugs | Full Text | References | PDF (175.2 KB)

561 Views
95 CrossRef citations
0Altmetric

Article

Pharmacological treatment of attention-deficit/hyperactivity disorder in adults

Joshua Slatkoff & Brian Greenfield

Pages: 649-667

Published online: 30 May 2006

AbstractforPharmacological treatment of attention-deficit/hyperactivity disorder in adults | Full Text | References | PDF (187.3 KB)

348 Views
7 CrossRef citations
0Altmetric

Article

Recent advances in targeting regulators of apoptosis in cancer cells for therapeutic gain

Kathryn Taylor, Dimitra Micha, Malcolm Ranson & Caroline Dive

Pages: 669-690

Published online: 30 May 2006

AbstractforRecent advances in targeting regulators of apoptosis in cancer cells for therapeutic gain | Full Text | References | PDF (979.9 KB)

119 Views
18 CrossRef citations
0Altmetric

Article

Epothilones in the treatment of cancer

James MG Larkin & Stanley B Kaye

Pages: 691-702

Published online: 30 May 2006

AbstractforEpothilones in the treatment of cancer | Full Text | References | PDF (169.3 KB)

211 Views
66 CrossRef citations
0Altmetric

Drug Evaluation

Article

INH-A21: a donor-selected Staphylococcal human immune globulin for the prevention of late-onset neonatal Staphylococcal infection

Barry T Bloom

Pages: 703-707

Published online: 30 May 2006

AbstractforINH-A21: a donor-selected Staphylococcal human immune globulin for the prevention of late-onset neonatal Staphylococcal infection | Full Text | References | PDF (107.4 KB)

40 Views
5 CrossRef citations
0Altmetric

Article

Lonafarnib in cancer therapy

Floriana Morgillo & Ho-Young Lee

Pages: 709-719

Published online: 30 May 2006

AbstractforLonafarnib in cancer therapy | Full Text | References | PDF (201.4 KB)

379 Views
40 CrossRef citations
0Altmetric

Meeting Highlights

Article

10th Anniversary Inflammation and Immune Diseases Drug Discovery and Development Summit

20 – 21 March 2006, New Brunswick, USA

Martin Braddock & Clare Murray

Pages: 721-727

Published online: 30 May 2006

Abstractfor10th Anniversary Inflammation and Immune Diseases Drug Discovery and Development Summit | Full Text | References | PDF (128.2 KB)

394 Views
5 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjects

Jian Liu et al.

Article | Published online: 12 Jul 2024

Open Access

Medical treatments for abdominal aortic aneurysm: an overview of clinical trials

Jinyi Chen et al.

Review Article | Published online: 11 Jul 2024

Open Access

Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity

Robert H Gaffey et al.

Review Article | Published online: 10 Jul 2024

Emerging treatment landscape for Guillain-Barré Syndrome (GBS): what’s new?

Alina Sprenger-Svačina et al.

Report | Published online: 10 Jul 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.15, Iss.6, 2006)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?